11 Feb, 2022 News Vaccine startup Curevo takes on pharma giant GSK, raises $60M for trial of shingles shot by curevovaccine
10 Feb, 2022 News, Press Releases, Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines by curevovaccine
10 Feb, 2022 News, Vaccines A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster. RA Capital is on board by curevovaccine
15 Sep, 2020 News, Vaccines Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101 by curevovaccine
26 Sep, 2019 News, Press Releases, Vaccines Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101 by curevovaccine